SARS-CoV-2 : beyond viral neutralization


On Friday, April 9th at noon, the CRCHUM Conference series will feature Andrès Finzi, a researcher with the CRCHUM’s Immunopathology Research Theme, an associate professor in the Université de Montréal’s Department of Microbiology, Infectiology and Immunology and the Canada Research Chair in Retroviral Entry.

Andrès Finzi will present his latest data analyzing the humoral response to the SARS‑CoV‑2 (WT and variants) spike glycoprotein. The role of the neutralizing response, as well as that of the antibody‑mediated effector response, will be discussed.
 


FRIDAY, APRIL 9, 2021 – 12 P.M. TO 1 P.M. 

> Subscribe to the conference

*You will receive a confirmation email containing the information you need to join the meeting.

Dr. Finzi is an associate professor in the Université de Montréal’s Department of Microbiology, Infectiology and Immunology. He is the Canada Research Chair in Retroviral Entry at the CRCHUM. He is a leader in research into conformational changes in HIV‑1 envelope glycoproteins, which are accessory HIV‑1 proteins, and the Fc fragment‑mediated effector functions of antibodies. He recently used his expertise to study humoral responses against the SARS-CoV-2 spike glycoprotein. His work has important implications for the development of new therapeutic strategies for fighting HIV‑1 and SARS‑CoV‑2. The excellence of Dr. Finzi’s research program has been recognized by many distinctions and awards. He has been a member of the College of New Scholars, Artists and Scientists of the Royal Society of Canada since November 2020.
 

Invited by Emmanuelle Brochiero
Immunopathology Theme

We look forward to seeing you connected in large numbers!
 


ABOUT CRCHUM CONFERENCES

The CRCHUM Conferences are free weekly meetings featuring renowned scientific speakers from various disciplines. 

> Schedule of the CRCHUM Conferences